Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01589198 · ClinicalTrials.gov registry record
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 110
- Enrollment target
NCT01589198 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 110 participants.
The verdict
NCT01589198 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about asthma in people who are not well-controlled with current asthma medication (refractory asthma). The investigators will compare data from refractory asthmatic patients here at National Jewish Health to mild asthmatics subjects and to people without asthma. Study experiments involve looking at samples from all 3 groups and comparing them at a molecular level. These laboratory experiments may help identify subtypes of refractory asthmatics that require different treatments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01589198
The ClinicalTrials.gov registry entry for NCT01589198 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01589198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01589198 about?
NCT01589198 is a clinical study titled "Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma". The purpose of this study is to learn more about asthma in people who are not well-controlled with current asthma medication (refractory asthma). The investigators will compare data from refractory asthmatic patients here at National Jewish Health to mild asthmatics subjects and to people without as...
What is the current status of trial NCT01589198?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2012-01. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT01589198?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.